Lunai Bioworks Inc. Shareholders' Equity
Lunai Bioworks Inc. (LNAI) had Shareholders' Equity of -$9.55 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-15
- 2026-03-31: Stockholders' Equity Attributable to Parent -$9.55M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$13.55M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$13.04M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$21.35M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | -$9.55M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$13.55M 10-Q · filed 2026-05-15 | |
| 2025-09-30 | -$13.04M 10-Q · filed 2026-05-15 | |
| 2025-06-30 | -$21.35M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $88.39M 10-Q · filed 2026-05-15 | $88.39M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $82.06M 10-Q · filed 2026-05-15 | $82.06M 10-Q · filed 2025-02-19 |
| 2024-09-30 | $98.09M 10-Q · filed 2026-05-15 | $98.09M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $131.98M 10-Q · filed 2026-05-15 | |
| 2024-03-31 | $134.41M 10-Q/A · filed 2025-02-19 | $168.60M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $43.60M 10-Q/A · filed 2025-02-19 | |
| 2023-09-30 | $46.75M 10-Q/A · filed 2025-02-19 | |
| 2023-06-30 | $46.50M 10-K · filed 2025-09-29 | |
| 2023-03-31 | $66.13M 10-Q/A · filed 2025-02-19 | |
| 2022-12-31 | $66.90M 10-Q/A · filed 2025-02-19 | |
| 2022-09-30 | $70.32M 10-Q/A · filed 2025-02-19 | |
| 2022-06-30 | $72.62M 10-Q/A · filed 2025-02-19 | |
| 2022-03-31 | $161.24M 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $165.62M 10-Q · filed 2023-05-12 | |
| 2021-09-30 | $166.97M 10-Q · filed 2023-05-12 | |
| 2021-06-30 | $174.66M 10-K · filed 2023-10-02 | |
| 2021-03-31 | $162.32M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $161.94M 10-Q · filed 2022-05-13 | |
| 2020-09-30 | $164.23M 10-Q · filed 2022-05-13 | |
| 2020-06-30 | $166.27M 10-K · filed 2023-02-27 | |
| 2020-03-31 | $170.22M 10-Q · filed 2021-05-17 | |
| 2019-12-31 | $171.28M 10-Q · filed 2021-05-17 | |
| 2019-09-30 | $172.18M 10-Q · filed 2021-05-17 | |
| 2019-06-30 | $173.10M 10-K · filed 2021-09-24 | |
| 2019-03-31 | $152.62M 10-Q · filed 2020-05-11 | $143.97M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $155.40M 10-Q · filed 2020-05-11 | $148.72M 10-Q · filed 2019-02-13 |
| 2018-09-30 | $158.38M 10-Q · filed 2020-05-11 | $153.59M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $158.74M 10-K · filed 2020-09-23 | $155.90M 10-K · filed 2018-10-01 |
| 2018-03-31 | -$143.36M 10-Q · filed 2019-05-16 | $143.36M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.85M 10-Q · filed 2019-05-16 | |
| 2017-09-30 | $2.76M 10-Q · filed 2019-05-16 | |
| 2017-06-30 | $1.53M 10-K · filed 2019-09-30 | |
| 2017-03-31 | -$1.61M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$1.28M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$797.99K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$637.40K 10-K · filed 2017-11-20 | |
| 2016-03-31 | -$63.39K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $441.77K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $717.02K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $1.08M 10-K · filed 2016-09-28 | |
| 2015-03-31 | $2.67M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $3.48M 10-KT · filed 2015-09-28 | |
| 2014-09-30 | -$2.38M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$2.63M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$2.35M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | -$1.68M 10-KT · filed 2015-09-28 | -$79.23K 10-Q · filed 2014-02-11 |
| 2013-09-30 | -$70.59K 10-Q · filed 2013-11-15 | |
| 2013-06-30 | -$54.18K 10-Q · filed 2013-08-15 | |
| 2013-03-31 | -$51.27K 10-Q · filed 2014-02-11 | |
| 2012-12-31 | -$4.37M 10-Q · filed 2014-11-13 | -$41.56K 10-Q · filed 2013-02-14 |
| 2012-09-30 | -$31.75K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$24.68K 10-Q · filed 2012-08-20 | |
| 2012-03-31 | -$13.68K 10-Q · filed 2014-02-11 | |
| 2011-12-31 | -$9.27K 10-Q · filed 2012-02-21 | |
| 2011-09-30 | $2.08K 10-Q · filed 2011-11-25 | |
| 2011-03-31 | -$8.73K 10-Q · filed 2014-02-11 | |
| 2011-01-17 | $0.00 10-K · filed 2012-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |